DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Oleclumab
Oleclumab
Predictive QSAR Tools to Aid in Early Process Development of Monoclonal Antibodies
Perioperative Systemic Treatment for Muscle-Invasive Bladder Cancer: Current Evidence and Future Perspectives
Stembook 2018.Pdf
NETTER, Jr., Robert, C. Et Al.; Dann, Dorf- (21) International Application
2018 Medicines in Development for Cancer
(INN) for Biological and Biotechnological Substances
H1 2020 Results
H1 2021 Results Clinical Trials Appendix PDF 2769KB
Astrazeneca Deals – Key Highlights
Filed by Astrazeneca PLC This Communication Is Filed Pursuant to Rule 425 Under the United States Securities Act of 1933 Subject Company: Alexion Pharmaceuticals, Inc
A61K9/51 (2006.01) — with International Search Report (Art
The State-Of-The-Art of Phase II/III Clinical Trials for Targeted Pancreatic Cancer Therapies
IASLC 2020 World Conference on Lung Cancer Singapore: Highlights
2020 Medicines in Development ꟷ Cancer
Compilation of Abstract Titles from ASCO Annual Meeting 2021 (Oral, Poster Discussion, Posters, Mains Track by Cancer Types Only)
Phage Display Derived Monoclonal Antibodies: from Bench to Bedside
(2006.01) C07d 413/14
The Latest Advancement in Pancreatic Ductal Adenocarcinoma Therapy: a Review Article for the Latest Guidelines and Novel Therapies
Top View
Increase in Price & Margin Improvement
What Science Can Do Can Science What
Clinical Trials Appendix Q1 2020 Results Update Movement Since Q4 2019 Update
Understanding Cancer Immunotherapy
Clinical Trials Appendix Q1 2019 Results Update
QSAR Model Development for Early Stage Screening of Monoclonal Antibody Therapeutics to Facilitate Rapid Developability
Clinical Trials Appendix Q1 2021 Results Update
Roswell Park Cancer Institute
A Guide to Clinical Trials in Pancreatic Cancer Pancreatic Cancer
A Focused Biopharmaceutical Company
Astrazeneca PLC 2 February 2018 07:00 Full-Year 2017 Results
Filed by Astrazeneca PLC This Communication Is Filed Pursuant to Rule 425 Under the United States Securities Act of 1933 Subject Company: Alexion Pharmaceuticals, Inc
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Clinical Trials Appendix FY 2019 Results Update Movement Since Q3 2019 Update